These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

598 related items for PubMed ID: 27935862

  • 1. Targeting of interleukin (IL)-17A inhibits PDL1 expression in tumor cells and induces anticancer immunity in an estrogen receptor-negative murine model of breast cancer.
    Ma YF, Chen C, Li D, Liu M, Lv ZW, Ji Y, Xu J.
    Oncotarget; 2017 Jan 31; 8(5):7614-7624. PubMed ID: 27935862
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers.
    Gray MJ, Gong J, Hatch MM, Nguyen V, Hughes CC, Hutchins JT, Freimark BD.
    Breast Cancer Res; 2016 May 11; 18(1):50. PubMed ID: 27169467
    [Abstract] [Full Text] [Related]

  • 4. Phospho‑STAT1 expression as a potential biomarker for anti‑PD‑1/anti‑PD‑L1 immunotherapy for breast cancer.
    Nakayama Y, Mimura K, Tamaki T, Shiraishi K, Kua LF, Koh V, Ohmori M, Kimura A, Inoue S, Okayama H, Suzuki Y, Nakazawa T, Ichikawa D, Kono K.
    Int J Oncol; 2019 Jun 11; 54(6):2030-2038. PubMed ID: 31081058
    [Abstract] [Full Text] [Related]

  • 5. Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model.
    Yu P, Steel JC, Zhang M, Morris JC, Waitz R, Fasso M, Allison JP, Waldmann TA.
    Proc Natl Acad Sci U S A; 2012 Apr 17; 109(16):6187-92. PubMed ID: 22474386
    [Abstract] [Full Text] [Related]

  • 6. Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer.
    Liu C, Liu R, Wang B, Lian J, Yao Y, Sun H, Zhang C, Fang L, Guan X, Shi J, Han S, Zhan F, Luo S, Yao Y, Zheng T, Zhang Y.
    J Immunother Cancer; 2021 Jan 17; 9(1):. PubMed ID: 33462141
    [Abstract] [Full Text] [Related]

  • 7. IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2.
    Cochaud S, Giustiniani J, Thomas C, Laprevotte E, Garbar C, Savoye AM, Curé H, Mascaux C, Alberici G, Bonnefoy N, Eliaou JF, Bensussan A, Bastid J.
    Sci Rep; 2013 Dec 09; 3():3456. PubMed ID: 24316750
    [Abstract] [Full Text] [Related]

  • 8. Immune parameters associated with survival in metaplastic breast cancer.
    Chao X, Liu L, Sun P, Yang X, Li M, Luo R, Huang Y, He J, Yun J.
    Breast Cancer Res; 2020 Aug 18; 22(1):92. PubMed ID: 32811533
    [Abstract] [Full Text] [Related]

  • 9. MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1.
    Li H, Li CW, Li X, Ding Q, Guo L, Liu S, Liu C, Lai CC, Hsu JM, Dong Q, Xia W, Hsu JL, Yamaguchi H, Du Y, Lai YJ, Sun X, Koller PB, Ye Q, Hung MC.
    Gastroenterology; 2019 May 18; 156(6):1849-1861.e13. PubMed ID: 30711629
    [Abstract] [Full Text] [Related]

  • 10. Chemotherapy induces enrichment of CD47+/CD73+/PDL1+ immune evasive triple-negative breast cancer cells.
    Samanta D, Park Y, Ni X, Li H, Zahnow CA, Gabrielson E, Pan F, Semenza GL.
    Proc Natl Acad Sci U S A; 2018 Feb 06; 115(6):E1239-E1248. PubMed ID: 29367423
    [Abstract] [Full Text] [Related]

  • 11. Interleukin (IL)-24 transforms the tumor microenvironment and induces anticancer immunity in a murine model of colon cancer.
    Ma YF, Ren Y, Wu CJ, Zhao XH, Xu H, Wu DZ, Xu J, Zhang XL, Ji Y.
    Mol Immunol; 2016 Jul 06; 75():11-20. PubMed ID: 27209087
    [Abstract] [Full Text] [Related]

  • 12. The mechanism of de novo expression of programmed cell death-ligand 1 in squamous cell carcinoma of the lung.
    Igarashi T, Teramoto K, Ishida M, Hanaoka J, Daigo Y.
    Oncol Rep; 2017 Oct 06; 38(4):2189-2196. PubMed ID: 28791392
    [Abstract] [Full Text] [Related]

  • 13. Topical treatment of all-trans retinoic acid inhibits murine melanoma partly by promoting CD8+ T-cell immunity.
    Yin W, Song Y, Liu Q, Wu Y, He R.
    Immunology; 2017 Oct 06; 152(2):287-297. PubMed ID: 28556970
    [Abstract] [Full Text] [Related]

  • 14. Expanded human NK cells from lung cancer patients sensitize patients' PDL1-negative tumors to PD1-blockade therapy.
    Poznanski SM, Ritchie TM, Fan IY, El-Sayes A, Portillo AL, Ben-Avi R, Rojas EA, Chew MV, Shargall Y, Ashkar AA.
    J Immunother Cancer; 2021 Jan 06; 9(1):. PubMed ID: 33479024
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antitumor immunity is defective in T cell-specific microRNA-155-deficient mice and is rescued by immune checkpoint blockade.
    Huffaker TB, Lee SH, Tang WW, Wallace JA, Alexander M, Runtsch MC, Larsen DK, Thompson J, Ramstead AG, Voth WP, Hu R, Round JL, Williams MA, O'Connell RM.
    J Biol Chem; 2017 Nov 10; 292(45):18530-18541. PubMed ID: 28912267
    [Abstract] [Full Text] [Related]

  • 18. IL-17A secreted from lymphatic endothelial cells promotes tumorigenesis by upregulation of PD-L1 in hepatoma stem cells.
    Wei Y, Shi D, Liang Z, Liu Y, Li Y, Xing Y, Liu W, Ai Z, Zhuang J, Chen X, Gao Q, Jiang J.
    J Hepatol; 2019 Dec 10; 71(6):1206-1215. PubMed ID: 31499129
    [Abstract] [Full Text] [Related]

  • 19. Upregulation of PD‑L1 expression by resveratrol and piceatannol in breast and colorectal cancer cells occurs via HDAC3/p300‑mediated NF‑κB signaling.
    Lucas J, Hsieh TC, Halicka HD, Darzynkiewicz Z, Wu JM.
    Int J Oncol; 2018 Oct 10; 53(4):1469-1480. PubMed ID: 30066852
    [Abstract] [Full Text] [Related]

  • 20. IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer.
    Mace TA, Shakya R, Pitarresi JR, Swanson B, McQuinn CW, Loftus S, Nordquist E, Cruz-Monserrate Z, Yu L, Young G, Zhong X, Zimmers TA, Ostrowski MC, Ludwig T, Bloomston M, Bekaii-Saab T, Lesinski GB.
    Gut; 2018 Feb 10; 67(2):320-332. PubMed ID: 27797936
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.